Norges Bank Takes Position in Cabot Corporation $CBT

Norges Bank bought a new position in Cabot Corporation (NYSE:CBTFree Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 749,269 shares of the specialty chemicals company’s stock, valued at approximately $49,662,000.

Several other hedge funds and other institutional investors also recently modified their holdings of CBT. Rothschild Investment LLC lifted its position in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 259 shares during the last quarter. Intech Investment Management LLC grew its position in Cabot by 31.6% in the 4th quarter. Intech Investment Management LLC now owns 26,552 shares of the specialty chemicals company’s stock worth $1,760,000 after purchasing an additional 6,372 shares during the last quarter. New Age Alpha Advisors LLC grew its position in Cabot by 125.8% in the 4th quarter. New Age Alpha Advisors LLC now owns 7,645 shares of the specialty chemicals company’s stock worth $507,000 after purchasing an additional 4,259 shares during the last quarter. Hantz Financial Services Inc. increased its stake in shares of Cabot by 131.0% in the fourth quarter. Hantz Financial Services Inc. now owns 991 shares of the specialty chemicals company’s stock valued at $66,000 after purchasing an additional 562 shares during the period. Finally, Jefferies Financial Group Inc. raised its holdings in shares of Cabot by 255.9% during the fourth quarter. Jefferies Financial Group Inc. now owns 36,570 shares of the specialty chemicals company’s stock valued at $2,424,000 after buying an additional 26,294 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Stock Down 0.0%

Cabot stock opened at $80.86 on Monday. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $89.46. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The firm has a market cap of $4.17 billion, a PE ratio of 15.28, a P/E/G ratio of 10.67 and a beta of 0.82. The firm’s 50 day moving average price is $79.11 and its two-hundred day moving average price is $73.09.

Cabot (NYSE:CBTGet Free Report) last released its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm’s revenue was down 3.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts predict that Cabot Corporation will post 6.32 EPS for the current fiscal year.

Cabot Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. This is a positive change from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. Cabot’s dividend payout ratio is currently 35.73%.

Analyst Ratings Changes

CBT has been the subject of a number of analyst reports. Wall Street Zen lowered Cabot from a “buy” rating to a “hold” rating in a research report on Saturday. UBS Group raised their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Mizuho increased their target price on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus target price of $80.25.

Get Our Latest Analysis on Cabot

Cabot Company Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

See Also

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.